✦ LIBER ✦

Discovery and Characterization of Atropisomer PH-797804, a p38 MAP Kinase Inhibitor, as a Clinical Drug Candidate

✍ Scribed by Dr. Li Xing; Dr. Balekudru Devadas; Dr. Rajesh V. Devraj; Dr. Shaun R. Selness; Dr. Huey Shieh; Dr. John K. Walker; Dr. Michael Mao; Dean Messing; Brian Samas; Dr. Jerry Z. Yang; Gary D. Anderson; Elizabeth G. Webb; Dr. Joseph B. Monahan

Book ID: 112066641
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 694 KB
Volume: 7
Category: Article
ISSN: 1860-7179
DOI: 10.1002/cmdc.201100439

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Discovery of PH-797

ChemInform Abstract: Discovery of PH-797804, a Highly Selective and Potent Inhibitor of p38 MAP Kinase.

✍ Shaun R. Selness; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 21 KB 👁 1 views

## Abstract The synthesis and SAR studies of a novel N‐aryl pyridinone class of p38 kinase inhibitors are described.

[RSC Drug Discovery] Anti-Inflammatory D

[RSC Drug Discovery] Anti-Inflammatory Drug Discovery || CHAPTER 5. Dual Inhibition of Phosphodiesterase-4 and p38 MAP Kinase: A Strategy for Treatment of Chronic Inflammatory Diseases

✍ Levin, Jeremy I. 📂 Article 📅 2012 🏛 Royal Society of Chemistry ⚖ 879 KB

5-Cyanopyrimidine Derivatives as a Novel

5-Cyanopyrimidine Derivatives as a Novel Class of Potent, Selective, and Orally Active Inhibitors of p38α MAP Kinase

✍ Liu, Chunjian; Wrobleski, Stephen T.; Lin, James; Ahmed, Gulzar; Metzger, Axel; 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 297 KB

Development of peptide inhibitor as a th

Development of peptide inhibitor as a therapeutic agent against head and neck squamous cell carcinoma (HNSCC) targeting p38α MAP kinase

✍ Gill, Kamaldeep; Singh, Abhay K.; Kapoor, Vaishali; Nigam, Lokesh; Kumar, Rahul; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 723 KB

Novel Inhibitor of p38 MAP Kinase as an

Novel Inhibitor of p38 MAP Kinase as an Anti-TNF-α Drug: Discovery of N -[4-[2-Ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a Potent and Orally Active Anti-Rheumatoid Arthritis Agent

✍ Miwatashi, Seiji; Arikawa, Yasuyoshi; Kotani, Etsuo; Miyamoto, Maki; Naruo, Ken- 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 382 KB

The discovery of N-cyclopropyl-4-methyl-

The discovery of N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide (AZD6703), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases

✍ Dearg S. Brown; John G. Cumming; Paul Bethel; Jonathan Finlayson; Stefan Gerhard 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 864 KB